October 25, 2021

 

Best Practices for Lifecycle Management in Biopharmaceuticals

The planning and execution of a robust lifecycle management (LCM) plan to optimize high-value branded pharmaceuticals, biotechnology products and platform technology franchises— all the way from clinical development through approval, launch, market growth, patent expiry and beyond—requires early planning, discipline, continuity and consistent resource allocation. However, too often, competing short-term business objectives divert time and attention from the development and implementation of an effective LCM strategy that supports the brand’s contribution beyond the patent cliff.

The stakes are higher than ever for both small/mid-sized drug developers and pharmaceutical market leaders, yet the challenges each type of company faces can differ significantly.

This four-part series will cover the essentials of LCM planning, development and execution for pharmaceutical, life sciences and biotechnology companies.

 

Subscribe to receive an email when each chapter is posted.

Scroll to Page Bottom Form 
Enabled